Avidity Partners Management as of Sept. 30, 2024
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 81 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 4.1 | $81M | 962k | 83.80 | |
| Dianthus Therapeutics (DNTH) | 4.1 | $80M | 2.9M | 27.38 | |
| Intuitive Surgical Com New (ISRG) | 3.7 | $73M | 148k | 491.27 | |
| Natera (NTRA) | 3.6 | $71M | 556k | 126.95 | |
| Cg Oncology (CGON) | 3.2 | $63M | 1.7M | 37.73 | |
| Acadia Healthcare (ACHC) | 3.2 | $63M | 985k | 63.41 | |
| Neurocrine Biosciences (NBIX) | 2.7 | $53M | 460k | 115.22 | |
| UnitedHealth (UNH) | 2.6 | $51M | 87k | 584.68 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.4 | $48M | 431k | 111.41 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $47M | 2.5M | 19.25 | |
| Perspective Therapeutics Com New (CATX) | 2.3 | $46M | 3.4M | 13.35 | |
| Glaukos (GKOS) | 2.3 | $45M | 345k | 130.28 | |
| Ideaya Biosciences (IDYA) | 2.2 | $44M | 1.4M | 31.68 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $43M | 592k | 73.00 | |
| Thermo Fisher Scientific (TMO) | 2.2 | $42M | 69k | 618.57 | |
| Tenet Healthcare Corp Com New (THC) | 2.1 | $42M | 253k | 166.20 | |
| Ultragenyx Pharmaceutical (RARE) | 2.1 | $42M | 752k | 55.55 | |
| Humana (HUM) | 2.1 | $41M | 130k | 316.74 | |
| EXACT Sciences Corporation (EXAS) | 2.0 | $40M | 588k | 68.12 | |
| Illumina (ILMN) | 1.9 | $38M | 292k | 130.41 | |
| Arvinas Ord (ARVN) | 1.9 | $37M | 1.5M | 24.63 | |
| Revolution Medicines (RVMD) | 1.8 | $36M | 790k | 45.35 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.7 | $34M | 2.1M | 15.99 | |
| Phathom Pharmaceuticals (PHAT) | 1.7 | $33M | 1.8M | 18.08 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $32M | 818k | 39.37 | |
| Avantor (AVTR) | 1.6 | $32M | 1.2M | 25.87 | |
| Blueprint Medicines (BPMC) | 1.5 | $29M | 315k | 92.50 | |
| Mirum Pharmaceuticals (MIRM) | 1.5 | $29M | 731k | 39.00 | |
| Surgery Partners (SGRY) | 1.4 | $27M | 827k | 32.24 | |
| Axsome Therapeutics (AXSM) | 1.4 | $27M | 296k | 89.87 | |
| Danaher Corporation (DHR) | 1.3 | $26M | 95k | 278.02 | |
| Janux Therapeutics (JANX) | 1.3 | $26M | 562k | 45.43 | |
| Neumora Therapeutics (NMRA) | 1.2 | $24M | 1.8M | 13.21 | |
| Kymera Therapeutics (KYMR) | 1.2 | $24M | 500k | 47.33 | |
| Biohaven (BHVN) | 1.2 | $23M | 465k | 49.97 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $23M | 320k | 70.29 | |
| Argenx Se Sponsored Adr (ARGX) | 1.1 | $21M | 38k | 542.08 | |
| Incyte Corporation (INCY) | 1.0 | $20M | 308k | 66.10 | |
| Abbvie (ABBV) | 1.0 | $20M | 100k | 197.48 | |
| Oruka Therapeutics | 1.0 | $19M | 791k | 24.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.0 | $19M | 431k | 43.89 | |
| Neurogene (NGNE) | 0.9 | $18M | 425k | 41.96 | |
| Terns Pharmaceuticals (TERN) | 0.9 | $18M | 2.1M | 8.34 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $18M | 119k | 149.31 | |
| Biontech Se Sponsored Ads (BNTX) | 0.9 | $17M | 145k | 118.77 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $17M | 233k | 73.17 | |
| Keros Therapeutics (KROS) | 0.9 | $17M | 293k | 58.07 | |
| Dex (DXCM) | 0.8 | $16M | 240k | 67.04 | |
| Oric Pharmaceuticals (ORIC) | 0.8 | $15M | 1.4M | 10.25 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.8 | $15M | 890k | 16.60 | |
| Context Therapeutics (CNTX) | 0.7 | $15M | 7.4M | 1.96 | |
| Zoetis Cl A (ZTS) | 0.7 | $14M | 71k | 195.38 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $14M | 749k | 18.47 | |
| Immunic (IMUX) | 0.7 | $14M | 8.3M | 1.65 | |
| Bristol Myers Squibb (BMY) | 0.7 | $14M | 263k | 51.74 | |
| Immunome (IMNM) | 0.7 | $13M | 874k | 14.62 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $12M | 1.1M | 10.49 | |
| Cogent Biosciences (COGT) | 0.6 | $11M | 1.0M | 10.80 | |
| Apogee Therapeutics (APGE) | 0.5 | $9.0M | 154k | 58.74 | |
| Privia Health Group (PRVA) | 0.4 | $8.5M | 467k | 18.21 | |
| Cybin Com New | 0.4 | $8.2M | 918k | 8.89 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $7.3M | 169k | 43.27 | |
| Cullinan Oncology (CGEM) | 0.4 | $7.1M | 425k | 16.74 | |
| Immunocore Hldgs Ads (IMCR) | 0.3 | $6.2M | 200k | 31.13 | |
| Dyne Therapeutics (DYN) | 0.3 | $5.9M | 165k | 35.92 | |
| Sanofi Sponsored Adr (SNY) | 0.3 | $5.8M | 100k | 57.63 | |
| Editas Medicine (EDIT) | 0.3 | $5.0M | 1.5M | 3.41 | |
| Transmedics Group (TMDX) | 0.2 | $4.3M | 28k | 157.00 | |
| Kezar Life Sciences (KZR) | 0.2 | $3.9M | 5.0M | 0.77 | |
| Uniqure Nv SHS (QURE) | 0.2 | $3.3M | 674k | 4.93 | |
| Immunovant (IMVT) | 0.1 | $2.8M | 99k | 28.51 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $2.7M | 240k | 11.44 | |
| Prime Medicine (PRME) | 0.1 | $2.7M | 694k | 3.87 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.1 | $2.3M | 1.1M | 2.15 | |
| Scynexis Com New (SCYX) | 0.1 | $2.2M | 1.4M | 1.49 | |
| Instil Bio Com New (TIL) | 0.1 | $2.0M | 29k | 67.32 | |
| Prelude Therapeutics (PRLD) | 0.1 | $1.8M | 890k | 2.07 | |
| Karyopharm Therapeutics (KPTI) | 0.1 | $1.7M | 2.0M | 0.83 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $1.3M | 1.2M | 1.08 | |
| Bluebird Bio (BLUE) | 0.0 | $847k | 1.6M | 0.52 | |
| Caremax Cl A New (CMAX) | 0.0 | $36k | 21k | 1.70 |
